Cash being raised at a serious premium to the current trading. Market is .13 by .14 and cash coming in at .20! Gives you an idea of the true value of the shares.

GOLDEN HOPE ANNOUNCES CLOSING OF FIRST TRANCHE OF
FINANCING
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED STATES
Toronto, Ontario – June 18, 2008 – Golden Hope Mines Limited (“Golden Hope” or the “Company”) (TSX-V: GNH and PK: GOLHF) is pleased to announce the closing of a private placement offering consisting of 2,150,000 flow-through common shares of the
Company (the “Flow-Through Shares”) at a price of $0.20 per Flow-Through Share (the “Offering”) for gross proceeds of $430,000. The Flow-Through Shares are subject to a
four month hold period expiring on October 19, 2008.

The company is in current negotiations with diverse parties to close the remainder of the planned financing. Golden Hope will use the proceeds from the Offering to advance the exploration on its
Bellechasse project in Quebec as well as for property acquisition and general working capital purposes.

The Company paid certain registered brokers (the “Brokers”) commission fees in the aggregate amount of $27,950. In addition, the Company issued 139,750 broker warrants (the “Broker Warrants”). Each Broker Warrant will entitle the holder to buy one
Common Share at $0.24 per Common Share. The Broker Warrants will be exercisable, in whole or in part, until December 18, 2009.

About Golden Hope: Golden Hope Mines Limited is a mineral exploration company that seeks to grow shareholder value through the acquisition, exploration and development of potentially large-scale gold, silver and base metal projects suitable for
underground and/or open-pit mining. The company’s two areas of interest are located in Quebec, Canada and Maine, U.S. The Bellechasse gold project in Quebec includes the Timmins and Ascot gold zones, the Coucou volcanic target and a number of newly
claimed serpentinite geological formations. For further information on Golden Hope, visit www.goldenhopemines.com.